|
FY2021
12 months to Dec 31, 2021
|
FY2020
7 months to Dec 31, 2020
|
|
|---|---|---|
| Cash Flows from Operating Activities: | ||
| Net loss | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Change in fair value of derivative warrant liabilities | ||
| Change in fair value of convertible promissory note | ||
| Financing Costs - derivative warrant liabilities | ||
| Net gain from investments held in Trust Account | ||
| Changes in operating assets and liabilities: | ||
| Accounts payable | ||
| Prepaid expenses | ||
| Accrued expenses | ||
| Accrued income tax | ||
| Franchise tax payable | ||
| Net cash provided by (used) in operating activities | ||
| Cash deposited in Trust Account | ||
| Cash Flows from Investing Activities | ||
| Cash deposited in Trust Account | ||
| Interest released from Trust Account | ||
| Net cash provided by (used) in investing activities | ||
| Cash Flows from Financing Activities: | ||
| Proceeds from convertible note | ||
| Proceeds from issuance of Class B common stock to Sponsor | ||
| Proceeds from note payable to related party | ||
| Repayment of advances to related party | ||
| Advances from related party | ||
| Repayment of advances from related party | ||
| Proceeds received from initial public offering, gross | ||
| Proceeds received from private placement | ||
| Offering costs paid | ||
| Net cash provided by financing activities | ||
| Net increase in cash | ||
| Forfeiture of Class B common stock | ||
| Offering costs included in accrued expenses | ||
| Deferred underwriting commissions in connection with the initial public offering | ||
| Initial value of Class A common stock subject to possible redemption | ||
| Cash - beginning of the period | ||
| Cash - end of the period | ||
| Supplemental disclosure of noncash activities: | ||
| Forfeiture of Class B common stock | ||
| Offering costs included in accrued expenses | ||
| Deferred underwriting commissions in connection with the initial public offering |
Loading...
